Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Preferred Shares Issued (2022)

Historic Preferred Shares Issued for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Q3 2022 value amounting to $27.3 million.

  • Orchestra BioMed Holdings' Preferred Shares Issued changed N/A to $27.3 million in Q3 2022 from the same period last year, while for Dec 2022 it was $137.2 million, marking a year-over-year change of. This contributed to the annual value of $109.8 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Orchestra BioMed Holdings' Preferred Shares Issued is $27.3 million.
  • In the past 5 years, Orchestra BioMed Holdings' Preferred Shares Issued registered a high of $82.6 million during Q2 2022, and its lowest value of $27.3 million during Q1 2022.